DexCom appointed Glenn Boehnlein as an independent director and granted him initial restricted stock units with a Fair Value of $500,000. The board’s expansion to thirteen members adds him to its Operations & Innovation and Audit committees, while a separate $347,500 annual Equity award is planned around the 2027 annual meeting.

Key Highlights

  • DexCom’s board now has thirteen directors after Glenn Boehnlein’s appointment.
  • The new director is eligible for a $347,500 restricted-stock-unit award around the 2027 annual meeting.
  • DexCom appointed Glenn S. Boehnlein to its board effective September 10, 2026.
  • The board increased to thirteen directors, and Boehnlein joined two committees.

DexCom, Inc. (NASDAQ: DXCM) appointed Glenn S. Boehnlein to its board effective September 10, 2026, alongside an initial equity grant with a fair value of $500,000. The appointment gives Boehnlein a board term ending at the 2027 annual meeting and adds him to two committees.

Board Appointment and Committee Roles

The board increased its size to thirteen directors when it appointed Boehnlein. DexCom’s board determined that Boehnlein qualifies as an independent director under applicable Securities Act standards and Nasdaq listing standards. The company said no arrangement or understanding supported his selection, and it said he has no direct or indirect material interest in a transaction requiring disclosure under the specified related-party transaction rules. Boehnlein also entered into DexCom’s standard Indemnity agreement for directors and executive officers.

Equity Awards and Future Vesting

The initial appointment award consists of restricted stock units with a fair value of $500,000. The award vests annually over the period following its grant and remains subject to Boehnlein’s continued service. Boehnlein will also be eligible for an annual restricted-stock-unit grant with a fair value of $347,500 around the 2027 annual meeting. That award will vest on the earlier of the first subsequent annual stockholder meeting or one year from its grant date, subject to continued service.